 |
SYDNEY, Aug. 20, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kazia's paxalisib (formerly GDC-0084) for the treatment of glioblastoma,...
Making the most of your home without having to move is actually a lot easier than you think. You don’t have to leave your family home just because y...
Nearly 80 percent of people are suffering from information overload, a number that is increasing rapidly, and business leaders need to tackle the ...
Many people like the idea of becoming entrepreneurs because of the perks that come with it. From interesting challenges to the luxury of being t...
The Ultimate Guide to ClickFunnels: What is it and How to Use it Whether you run a small business or are in charge of marketing for a large cor...
You have a breakthrough idea and a killer business plan for your startup. A talented workforce is ready to take on any challenges in the market. It ...
People purchase properties because of rental payments and the gradual appreciation of the property. However, there are cases where people purchase p...